Brad Amman serves as the Chief Financial Officer at Vivos Therapeutics, Inc., where he leverages over 25 years of extensive experience in financial and operational leadership to drive the company’s strategic growth initiatives. With a robust background in both public and private equity, Amman plays...
Brad Amman serves as the Chief Financial Officer at Vivos Therapeutics, Inc., where he leverages over 25 years of extensive experience in financial and operational leadership to drive the company’s strategic growth initiatives. With a robust background in both public and private equity, Amman plays a pivotal role in navigating the complexities of financial management within the healthcare sector, particularly in the innovative field of obstructive sleep apnea (OSA) treatment. His expertise encompasses a wide range of financial disciplines, including cash flow management, SEC reporting, and corporate governance, which are critical in ensuring compliance and fostering investor confidence.
At Vivos, Amman is instrumental in overseeing key projects that involve the distribution of breakthrough medical devices and treatment protocols designed to address OSA and related health issues. His strategic planning and forecasting skills enable the company to effectively allocate resources and optimize operational efficiencies, ultimately enhancing patient outcomes. By implementing rigorous financial modeling and benchmarking practices, he ensures that Vivos remains competitive in a rapidly evolving market.
Amman’s leadership extends beyond traditional financial oversight; he actively collaborates with dental professionals and cross-functional teams to align financial strategies with clinical objectives. His commitment to executive management and corporate governance not only strengthens Vivos’s financial foundation but also fosters a culture of transparency and accountability. As the company continues to innovate and expand its reach, Brad Amman’s financial acumen and strategic insights are vital in steering Vivos Therapeutics toward sustained success and improved patient care.
